TWM659071U - Physiological sensing device - Google Patents
Physiological sensing device Download PDFInfo
- Publication number
- TWM659071U TWM659071U TW112212526U TW112212526U TWM659071U TW M659071 U TWM659071 U TW M659071U TW 112212526 U TW112212526 U TW 112212526U TW 112212526 U TW112212526 U TW 112212526U TW M659071 U TWM659071 U TW M659071U
- Authority
- TW
- Taiwan
- Prior art keywords
- angle
- edge
- sensing device
- insertion portion
- biochemical sensor
- Prior art date
Links
- 238000003780 insertion Methods 0.000 claims abstract description 77
- 230000037431 insertion Effects 0.000 claims abstract description 77
- 230000007480 spreading Effects 0.000 claims abstract description 6
- 238000005452 bending Methods 0.000 claims description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- -1 polyethylene Polymers 0.000 description 5
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
Abstract
Description
本創作涉及一種監測體液的技術領域,特別是提供一種生理感測裝置。This invention relates to a technical field of monitoring body fluids, and in particular provides a physiological sensing device.
近年來,利用檢測或監控人體體液以確定身體特徵是現代人很重視的層面,前述的人體體液例如為葡萄糖、乳酸或糖化血色素(HbA1c)等。以糖尿病為例,即時且週期性監測體液中血糖濃度對糖尿病患者是必要的,因此,自動化監測體液的裝置為近年來開發的方向之一。In recent years, the use of testing or monitoring human body fluids to determine physical characteristics has become a very important aspect for modern people. The aforementioned human body fluids are, for example, glucose, lactic acid or glycosylated hemoglobin (HbA1c). Taking diabetes as an example, real-time and periodic monitoring of blood sugar concentration in body fluids is necessary for diabetic patients. Therefore, automated monitoring of body fluids has become one of the development directions in recent years.
糖尿病是現代人常見的慢性醫學疾病,根據國際糖尿病聯盟(International Diabetes Federation)在2021年的數據報告顯示,糖尿病的發病率在全球已達到9.3%。糖尿病是由於胰島素分泌不足所引起的疾病,造成糖尿病的原因包含肥胖、壓力、不良的飲食習慣、遺傳等因素。Diabetes is a common chronic medical disease among modern people. According to the data report of the International Diabetes Federation in 2021, the incidence of diabetes has reached 9.3% worldwide. Diabetes is a disease caused by insufficient secretion of insulin. The causes of diabetes include obesity, stress, bad eating habits, genetic factors and other factors.
糖尿病患者經常處在高血糖和低血糖之間,患者如果在長時間處於低血糖狀況下且沒有得到足夠的碳水化合物,可能會導致糖尿病患者失去意識甚至死亡。因此,即時發現糖尿病患者處於低血糖狀態是非常重要的事。Diabetic patients often experience high and low blood sugar levels. If a patient is in a low blood sugar state for a long time and does not get enough carbohydrates, it may cause the diabetic patient to lose consciousness or even die. Therefore, it is very important to detect when a diabetic patient is in a low blood sugar state in time.
為了能夠提升血糖測量的準確性和即時性,近年來研發人員致力於開發連續性血糖監測系統(Continuous Glucose Monitoring,CGM),讓使用者可以連續性的監控血糖狀態,以即時對使用者進行治療和緊急應對措施。因此,連續性血糖監測系統的改良一直是相關業者和研究人員不斷追求的目標。In order to improve the accuracy and timeliness of blood sugar measurement, researchers have been working on developing continuous glucose monitoring (CGM) systems in recent years, allowing users to continuously monitor their blood sugar status and provide timely treatment and emergency response measures. Therefore, the improvement of continuous glucose monitoring systems has always been a goal that relevant industry players and researchers have been pursuing.
傳統上,生理感測裝置由於結構設計不良,在操作過程中會因為生化感測器的磨損,進而導致後續測量不準確的問題產生,因此需要一種結構改良的生理感測裝置。Traditionally, due to poor structural design, physiological sensing devices may wear out biochemical sensors during operation, resulting in inaccurate subsequent measurements. Therefore, a physiological sensing device with an improved structure is needed.
本創作的生理感測裝置包含生化感測器及針體,其中針體從針尖起依序包含相連的插入部及撐開部,插入部更包含相連的第一插入部及第二插入部,撐開部更包含與第二插入部相連的緩衝部及與緩衝部相連的擴大部;針體係板材基於對稱軸向內彎折後而成,並形成有槽,生化感測器係設置在槽中;第一插入部的邊緣的起點與終點之連線與對稱軸之間具有第一夾角θ1,第二插入部的邊緣的起點與終點之連線與對稱軸之間具有第二夾角θ2,緩衝部的邊緣的起點與終點之連線與對稱軸之間具有第三夾角θ3,擴大部的邊緣的起點與終點之連線與對稱軸之間具有第四夾角θ4。The physiological sensing device of the invention comprises a biochemical sensor and a needle body, wherein the needle body comprises an insertion part and an extension part connected from the needle tip in sequence, the insertion part further comprises a first insertion part and a second insertion part connected, the extension part further comprises a buffer part connected to the second insertion part and an expansion part connected to the buffer part; the needle body is formed by bending a plate inwardly based on a symmetry axis and forming a groove, and the biochemical sensor is provided In the groove, a first angle θ1 is formed between a line connecting a starting point and an end point of an edge of the first insertion portion and the symmetry axis, a second angle θ2 is formed between a line connecting a starting point and an end point of an edge of the second insertion portion and the symmetry axis, a third angle θ3 is formed between a line connecting a starting point and an end point of an edge of the buffer portion and the symmetry axis, and a fourth angle θ4 is formed between a line connecting a starting point and an end point of an edge of the expansion portion and the symmetry axis.
於本創作的至少一實施例中,針體還包含形成槽之內部殼體,內部殼體容納生化感測器。In at least one embodiment of the present invention, the needle body further includes an inner shell forming a groove, and the inner shell accommodates the biochemical sensor.
於本創作的至少一實施例中,內部殼體包含彼此相對且平行之第一面及第二面;在與對稱軸垂直的第一方向上,第一面與第二面之間的距離大於生化感測器的寬度。In at least one embodiment of the present invention, the inner shell includes a first surface and a second surface that are opposite to each other and parallel; in a first direction perpendicular to the axis of symmetry, the distance between the first surface and the second surface is greater than the width of the biochemical sensor.
於本創作的至少一實施例中,第四夾角θ4大於第三夾角θ3,第三夾角θ3大於第二夾角θ2,第二夾角θ2大於第一夾角θ1。In at least one embodiment of the present invention, the fourth angle θ4 is greater than the third angle θ3, the third angle θ3 is greater than the second angle θ2, and the second angle θ2 is greater than the first angle θ1.
於本創作的至少一實施例中,生化感測器的形狀與內部殼體的形狀不同。In at least one embodiment of the present invention, the shape of the biochemical sensor is different from the shape of the inner shell.
於本創作的至少一實施例中,第一面在垂直第一方向與對稱軸的一第二方向上具有第一長度,第二面在第二方向上具有第二長度;內部殼體底部沿該第二方向的最低點至第一面之底部邊緣的長度與第一長度的總和大於等於生化感測器沿該第二方向的高度;內部殼體底部沿該第二方向的最低點至第二面之底部邊緣的長度與第二長度的總和大於等於生化感測器沿該第二方向的高度。In at least one embodiment of the present invention, the first surface has a first length in a second direction perpendicular to the first direction and the axis of symmetry, and the second surface has a second length in the second direction; the sum of the length from the lowest point of the bottom of the inner shell along the second direction to the bottom edge of the first surface and the first length is greater than or equal to the height of the biochemical sensor along the second direction; the sum of the length from the lowest point of the bottom of the inner shell along the second direction to the bottom edge of the second surface and the second length is greater than or equal to the height of the biochemical sensor along the second direction.
於本創作的至少一實施例中,第一長度等於第二長度。In at least one embodiment of the present invention, the first length is equal to the second length.
於本創作的至少一實施例中,第一夾角θ1、第二夾角θ2、第三夾角θ3及第四夾角θ4均為銳角。In at least one embodiment of the present invention, the first angle θ1, the second angle θ2, the third angle θ3 and the fourth angle θ4 are all sharp angles.
於本創作的至少一實施例中,第一夾角θ1與第二夾角θ2的總和介於0°至90°之間,第二夾角θ2與第三夾角θ3的總和介於0°至90°之間,第三夾角θ3與第四夾角θ4的總和介於0°至90°之間。In at least one embodiment of the present invention, the sum of the first angle θ1 and the second angle θ2 is between 0° and 90°, the sum of the second angle θ2 and the third angle θ3 is between 0° and 90°, and the sum of the third angle θ3 and the fourth angle θ4 is between 0° and 90°.
於本創作的至少一實施例中,第一插入部的邊緣、第二插入部的邊緣、緩衝部的邊緣、擴大部的邊緣中的至少之一為圓弧邊緣。In at least one embodiment of the present invention, at least one of the edge of the first insertion portion, the edge of the second insertion portion, the edge of the buffer portion, and the edge of the expansion portion is an arc edge.
於本創作的至少一實施例中,第一插入部的邊緣、第二插入部的邊緣、緩衝部的邊緣、擴大部的邊緣皆為圓弧邊緣。In at least one embodiment of the present invention, the edge of the first insertion portion, the edge of the second insertion portion, the edge of the buffer portion, and the edge of the expansion portion are all arc edges.
於本創作的至少一實施例中,第一插入部的邊緣的圓弧半徑介於5.5mm至6mm之間;第二插入部的邊緣的圓弧半徑介於10mm至10.8mm之間。In at least one embodiment of the present invention, the arc radius of the edge of the first insertion portion is between 5.5 mm and 6 mm; the arc radius of the edge of the second insertion portion is between 10 mm and 10.8 mm.
於本創作的至少一實施例中,緩衝部的邊緣的圓弧半徑介於19.35mm至20mm之間;以及擴大部的邊緣的圓弧半徑介於0.2mm至2.4mm之間In at least one embodiment of the present invention, the arc radius of the edge of the buffer portion is between 19.35 mm and 20 mm; and the arc radius of the edge of the expansion portion is between 0.2 mm and 2.4 mm.
本創作所提供的生理感測裝置可減少針體和生化感測器的接觸面積,同時降低生化感測器的磨損,並提高血糖測量的準確率。The physiological sensing device provided by this invention can reduce the contact area between the needle and the biochemical sensor, reduce the wear of the biochemical sensor, and improve the accuracy of blood sugar measurement.
能充分瞭解本創作的目的、特徵及功效,藉由下述具體的實施例,並配合所附的圖式,對本創作做詳細的說明如後。In order to fully understand the purpose, features and effects of this invention, the invention is described in detail through the following specific embodiments and the attached drawings.
於本創作中,使用「一」或「一個」來描述本文所述的單元、元件和組件。此舉只是為了方便說明,並且對本創作的範圍提供一般性的意義。因此,除非很明顯地另指他意,否則此種描述應理解為包括一個、至少一個,且單數亦同時包括複數。In this invention, "a" or "an" is used to describe the units, elements and components described herein. This is only for convenience of explanation and to provide a general meaning to the scope of this invention. Therefore, unless it is obvious that it is otherwise intended, such description should be understood to include one, at least one, and the singular also includes the plural.
於本創作中,用語「包含」、「包括」、「具有」、「含有」或其他任何類似的用語意欲涵蓋非排他性的包括物。舉例而言,含有複數要件的一元件、結構、製品或裝置不僅限於本文所列出的此等要件而已,而是可以包括未明確列出但卻是該元件、結構、製品或裝置通常固有的其他要件。除此之外,除非有相反的明確說明,用語「或」是指涵括性的「或」,而不是指排他性的「或」 In this work, the terms "include", "including", "have", "contain" or any other similar terms are intended to cover non-exclusive inclusions. For example, an element, structure, product or device containing multiple elements is not limited to those listed herein, but may include other elements that are not expressly listed but are generally inherent to the element, structure, product or device. In addition, unless expressly stated to the contrary, the term "or" refers to an inclusive "or" rather than an exclusive "or"
本創作之一種生理感測裝置包含針體及生化感測器。針體從針尖起依序包含相連的插入部及撐開部,插入部更包含相連的第一插入部及第二插入部,撐開部更包含與第二插入部相連的一緩衝部及與緩衝部相連的一擴大部。針體係一板材基於一對稱軸向內彎折後而成,並形成有一槽,生化感測器係設置在槽中。 A physiological sensing device of the invention includes a needle body and a biochemical sensor. The needle body includes an insertion portion and a spreading portion connected from the needle tip in sequence, the insertion portion further includes a first insertion portion and a second insertion portion connected, and the spreading portion further includes a buffer portion connected to the second insertion portion and an expansion portion connected to the buffer portion. The needle body is formed by bending a plate inwardly based on a symmetry axis and forming a groove, and the biochemical sensor is arranged in the groove.
如圖1所示之一實施例,生理感測裝置10包含針體12及生化感測器18,針體12還包含外部殼體14及內部殼體16,此內部殼體16形成一槽以容置的生化感測器18。 As shown in FIG. 1 , a physiological sensing device 10 includes a needle body 12 and a biochemical sensor 18. The needle body 12 also includes an outer shell 14 and an inner shell 16. The inner shell 16 forms a groove to accommodate the biochemical sensor 18.
如圖1所示,內部殼體16包含沿針體12彎折之對稱軸(亦即y方向)延伸的第一邊22及第二邊24,第一邊22沿x方向縱向延伸形成第一面26,第二邊24沿x方向縱向延伸形成第二面28,且第一面26及第二面28彼此相對且平行。此外,第一面26與第二面28彼此不連接,而第一面26與第二面28之間沿z方向的距離大於生化感測器18沿z方向的寬度。相較於第一面26與第二面28為平坦面,內部殼體16可具有曲面以連結第一面26之第一邊22與第二面28之第二邊24,但本創作不欲侷限於此。 As shown in FIG. 1 , the inner shell 16 includes a first side 22 and a second side 24 extending along the symmetry axis (i.e., the y direction) of the needle body 12 bending, the first side 22 extending longitudinally along the x direction to form a first surface 26, the second side 24 extending longitudinally along the x direction to form a second surface 28, and the first surface 26 and the second surface 28 are opposite to each other and parallel. In addition, the first surface 26 and the second surface 28 are not connected to each other, and the distance between the first surface 26 and the second surface 28 along the z direction is greater than the width of the biochemical sensor 18 along the z direction. Compared with the first surface 26 and the second surface 28 being flat surfaces, the inner shell 16 may have a curved surface to connect the first side 22 of the first surface 26 and the second side 24 of the second surface 28, but the present invention is not intended to be limited to this.
進一步如圖1所示,第一面26在x方向上具有第一長度H1,第二面28在x方向上具有第二長度H2,第一長度H1與第二長度H2相等,亦即第一長度H1與第二長度H2的比例為1:1。在另一實施例中,第一長度和第二長度不相等。另外,針體12的內部殼體16具有沿x方向的縱向長度Hc,此縱向長度Hc定義為內 部殼體16在x方向上的最低點至第一面26之底部邊緣(即第一邊22)或第二面28之底部邊緣(即第二邊24)的距離。 As further shown in FIG. 1 , the first surface 26 has a first length H1 in the x-direction, and the second surface 28 has a second length H2 in the x-direction, and the first length H1 is equal to the second length H2, that is, the ratio of the first length H1 to the second length H2 is 1:1. In another embodiment, the first length and the second length are not equal. In addition, the inner shell 16 of the needle body 12 has a longitudinal length Hc along the x-direction, and the longitudinal length Hc is defined as the distance from the lowest point of the inner shell 16 in the x-direction to the bottom edge of the first surface 26 (i.e., the first side 22) or the bottom edge of the second surface 28 (i.e., the second side 24).
特別地,由於本創作的內部殼體16在x方向上的最高點到最低點的距離需大於或等於生化感測器18在x方向上的長度W,如此能讓生化感測器18保持在內部殼體16所形成的槽內。換言之,第一面26的第一長度H1和內部殼體16的縱向長度Hc的總和大於或等於生化感測器18在x方向上的長度W。在另一實施例中,第二面28的第二長度H2和內部殼體16的縱向長度Hc的總和大於或等於生化感測器18的長度W。藉此,當生化感測器18以這種方式被包覆於針體12之中時,而減小生化感測器18在針體12插入人體的過程中直接與皮膚產生接觸而導致的磨損。 In particular, since the distance from the highest point to the lowest point of the inner shell 16 in the x-direction of the present invention needs to be greater than or equal to the length W of the biochemical sensor 18 in the x-direction, the biochemical sensor 18 can be kept in the groove formed by the inner shell 16. In other words, the sum of the first length H1 of the first surface 26 and the longitudinal length Hc of the inner shell 16 is greater than or equal to the length W of the biochemical sensor 18 in the x-direction. In another embodiment, the sum of the second length H2 of the second surface 28 and the longitudinal length Hc of the inner shell 16 is greater than or equal to the length W of the biochemical sensor 18. Thus, when the biochemical sensor 18 is encapsulated in the needle body 12 in this way, the abrasion caused by the biochemical sensor 18 directly contacting the skin during the process of the needle body 12 being inserted into the human body is reduced.
此外,為了改善生化感測器18和內部殼體16的摩擦接觸,而導致電極面20磨損並使得後續測量誤差的問題,當生化感測器18的形狀為方形時,內部殼體16與生化感測器18之間至多具有二個接觸點,這樣能使生化感測器18與針體12的接觸面積降到最小。 In addition, in order to improve the frictional contact between the biochemical sensor 18 and the inner housing 16, which causes the electrode surface 20 to be worn and causes subsequent measurement errors, when the shape of the biochemical sensor 18 is square, there are at most two contact points between the inner housing 16 and the biochemical sensor 18, which can minimize the contact area between the biochemical sensor 18 and the needle body 12.
在另一實施例中,當生化感測器18的形狀為圓柱形時,內部殼體16與生化感測器18之間只有一個接觸點,這樣亦能使生化感測器18與針體12的接觸面積降到最小。 In another embodiment, when the biochemical sensor 18 is cylindrical in shape, there is only one contact point between the inner shell 16 and the biochemical sensor 18, which can also minimize the contact area between the biochemical sensor 18 and the needle body 12.
此外,生化感測器18的形狀係設計和針體12的內部殼體16的形狀不同,生化感測器18和內結構產生接觸後會預留部分的空間且保有特定的面積不受彼此接觸,進而減小生化感測器18和針體12結構的接觸面積」,最終共同達到降低生化感測器18的磨損並同時提高生理特徵(例如血糖)的測量準確率。In addition, the shape of the biochemical sensor 18 is designed to be different from the shape of the internal shell 16 of the needle body 12. After the biochemical sensor 18 and the internal structure come into contact, some space will be reserved and a specific area will be kept from contacting each other, thereby reducing the contact area between the biochemical sensor 18 and the needle body 12 structure. Ultimately, the wear of the biochemical sensor 18 is reduced and the measurement accuracy of physiological characteristics (such as blood sugar) is improved at the same time.
在一實施例中,針體12的材料可以選自由鋼(steel,例如為不鏽鋼)、陶瓷(ceramics)、鈦(titanium)、鉭(tantalum)、鎳(nickel)、鎳-鈦(nickel-titanium)、銥(iridium)、銀(silver)、鈀(palladium)、鉑-銥(platinum-iridium)、銥(iridium)、複合材料(composites)、上述組合之合金(alloys)及類似物所組成的群組之一。In one embodiment, the material of the needle body 12 can be selected from one of the groups consisting of steel (e.g., stainless steel), ceramics, titanium, tantalum, nickel, nickel-titanium, iridium, silver, palladium, platinum-iridium, iridium, composites, alloys of the above combinations, and the like.
在另一實施例中,針體12的材料係由聚合物組成。聚合物可以選自由聚碳酸酯(polycarbonate)、聚甲基丙烯酸(polymethacrylic acid)、乙烯乙酸乙烯酯(ethylene vinyl acetate)、聚酯(polyesters)、含氟聚合物(fluoropolymers)、聚乙烯(polyethylene)、聚丙烯(polypropylene)、高密度聚乙烯(high density polyethylene)、尼龍(nylons)、聚對苯二甲酸乙二醇酯(polyethylene terephthalate)、丙烯腈-丁二烯-苯乙烯(ABS)塑膠、SUS301醫療不鏽鋼、SUS316、金屬、堅硬塑膠、熱塑性材料,液晶聚合物(LCP)、聚醚醚酮材料及其組合所組成的群組之一,其中含氟聚合物可以是聚四氟乙烯(polytetrafluorethylene,TEFLON®)。以上列舉的針體12的材料僅作為示例性說明,針體12的材質並不以上述材料為限。In another embodiment, the material of the needle body 12 is composed of a polymer. The polymer can be selected from one of the groups consisting of polycarbonate, polymethacrylic acid, ethylene vinyl acetate, polyesters, fluoropolymers, polyethylene, polypropylene, high-density polyethylene, nylons, polyethylene terephthalate, acrylonitrile-butadiene-styrene (ABS) plastic, SUS301 medical stainless steel, SUS316, metal, hard plastic, thermoplastic material, liquid crystal polymer (LCP), polyetheretherketone material and a combination thereof, wherein the fluoropolymer can be polytetrafluoroethylene (TEFLON®). The materials of the needle body 12 listed above are only exemplary, and the material of the needle body 12 is not limited to the above materials.
在各種實施例中,針體12的內部殼體16在x方向上的最高點到最低點的距離需大於或等於生化感測器18在x方向上的長度W,針體12的剖面形狀可包含方形及長方形等變體;生化感測器18的剖面形狀可包含方形、長方形、圓柱形及橢圓柱形等變體;外部殼體14的剖面形狀可包含方形、長方形、不規則形、弧形及半橢圓形等變體;內部殼體16的剖面形狀可包含弧形、方形及半圓形等變體。換言之,圖1中所示的第一面26和第二面28的剖面形狀可變換為彎斜形、彎弧形、內彎形、長方形等等。以上列舉的形狀僅作為示例性說明,並不以上述形狀為限。 In various embodiments, the distance from the highest point to the lowest point of the inner shell 16 of the needle body 12 in the x-direction needs to be greater than or equal to the length W of the biochemical sensor 18 in the x-direction. The cross-sectional shape of the needle body 12 can include square and rectangular variants; the cross-sectional shape of the biochemical sensor 18 can include square, rectangular, cylindrical and elliptical cylindrical variants; the cross-sectional shape of the outer shell 14 can include square, rectangular, irregular, arc and semi-elliptical variants; the cross-sectional shape of the inner shell 16 can include arc, square and semi-circular variants. In other words, the cross-sectional shapes of the first surface 26 and the second surface 28 shown in FIG. 1 can be changed to be curved, curved, inner curved, rectangular, etc. The shapes listed above are for illustrative purposes only and are not limited to the above shapes.
如圖2所示之一實施例,以仰視的方式進一步描述針體12的外部殼體14、內部殼體16、第一面26及第二面28的剖面形狀。外部殼體14的剖面形狀例如為半橢圓形(2a、2h)、弧形(2d)、方形(2b、2c、2e)、不規則形(2f、2g、2i)。內部殼體16的剖面形狀例如為半圓形(2a、2c、2d、2e、2f、2g、2h)、方形(2b)、弧形(2i)。生化感測器18的剖面形狀例如為長方形(2a、2c、2d、2e、2f、2g、2h、2)及圓柱形(2b)。第一面26及第二面28可例如為直面(2a、2b、2c、2d、2e)、彎斜面(2f)、內彎面(2g)、彎弧面(2h)及部分弧面(2i)。以上列舉的形狀僅作為示例性說明,並不以上述形狀為限,但無論在各種變體中,針體12的內部殼體16在x方向上的最高點到最低點的距離都大於或等於生化感測器18在x方向上的長度。 As shown in FIG. 2 , the cross-sectional shapes of the outer shell 14, the inner shell 16, the first surface 26 and the second surface 28 of the needle body 12 are further described in a bottom-up manner. The cross-sectional shape of the outer shell 14 is, for example, a semi-ellipse (2a, 2h), an arc (2d), a square (2b, 2c, 2e), and an irregular shape (2f, 2g, 2i). The cross-sectional shape of the inner shell 16 is, for example, a semi-circle (2a, 2c, 2d, 2e, 2f, 2g, 2h), a square (2b), and an arc (2i). The cross-sectional shape of the biochemical sensor 18 is, for example, a rectangle (2a, 2c, 2d, 2e, 2f, 2g, 2h, 2) and a cylinder (2b). The first surface 26 and the second surface 28 may be, for example, straight surfaces (2a, 2b, 2c, 2d, 2e), curved surfaces (2f), inner curved surfaces (2g), curved surfaces (2h) and partial curved surfaces (2i). The above-listed shapes are only for illustrative purposes and are not limited to the above-listed shapes. However, in all variants, the distance from the highest point to the lowest point of the inner shell 16 of the needle body 12 in the x-direction is greater than or equal to the length of the biochemical sensor 18 in the x-direction.
補充說明的是,本創作人發現,在實際操作生理感測裝置時,針體輔助生化感測器進入皮下組織的過程中,針體與受測者的肌肉之間產生阻力、針體與生化感測器在製作過程中產生的允許公差等因素,使得針體與生化感測器在進入皮下組織的過程中產生位移,進而導致生化感測器與針體之間有摩擦接觸,然而針體的內部殼體的形狀與生化感測器的形狀不同,兩者之間仍保有特定的距離間隙,亦即彼此之間仍維持有特定的面積不會接觸,故能降低生化感測器與針體之間因摩擦接觸導致變形或受損的問題。 It is to be noted that the author of the present invention has found that when the physiological sensing device is actually operated, the needle assists the biochemical sensor to enter the subcutaneous tissue. The resistance between the needle and the subject's muscle and the tolerance of the needle and the biochemical sensor during the manufacturing process cause the needle and the biochemical sensor to shift during the process of entering the subcutaneous tissue, which in turn causes frictional contact between the biochemical sensor and the needle. However, the shape of the inner shell of the needle is different from that of the biochemical sensor, and there is still a specific distance gap between the two, that is, there is still a specific area between them that does not touch each other, so the problem of deformation or damage caused by frictional contact between the biochemical sensor and the needle can be reduced.
如圖3所示之一實施例,進一步說明生化感測器18與針體12的結構。生化感測器18的形狀為長方體,生化感測器18與針體12的內部殼體之間至多有具兩個接觸點A、B,這樣可以減少生化感測器18與針體12的接觸面積,以降低電極面與針體12直接接觸的可能性。另外,生化感測器18包含電極面(圖3未示出),針體12的內部殼體的形狀為半圓形,半圓形內部殼體可保護生化感測器18的電極面,以及減少因接觸而造成的損壞問題,進而提高生理測量的準確率。As shown in FIG3 , an embodiment further illustrates the structure of the biochemical sensor 18 and the needle body 12. The biochemical sensor 18 is in the shape of a rectangular parallelepiped, and there are at most two contact points A and B between the biochemical sensor 18 and the inner shell of the needle body 12, which can reduce the contact area between the biochemical sensor 18 and the needle body 12 to reduce the possibility of direct contact between the electrode surface and the needle body 12. In addition, the biochemical sensor 18 includes an electrode surface (not shown in FIG3 ), and the inner shell of the needle body 12 is in the shape of a semicircle. The semicircular inner shell can protect the electrode surface of the biochemical sensor 18 and reduce the damage caused by contact, thereby improving the accuracy of physiological measurement.
圖4之y-x平面剖面圖進一步顯示如圖1至圖3所示的針體12之尖端部份結構之實施例。而以尖端為起點,針體12包含插入部30及撐開部40,插入部30與撐開部40相連。插入部30與撐開部40較佳是一體成型。詳言之,插入部30包含第一插入部32及第二插入部34,第二插入部34係從第一插入部32的終點延伸,第一插入部32與第二插入部34相連。撐開部40包含緩衝部42及擴大部44,緩衝部42係從第二插入部34的終點延伸,擴大部44係從緩衝部42的終點延伸,緩衝部42與第二插入部34及擴大部44相連。The y-x plane cross-sectional view of FIG4 further shows an embodiment of the tip portion structure of the needle body 12 as shown in FIG1 to FIG3. Starting from the tip, the needle body 12 includes an insertion portion 30 and a propping portion 40, and the insertion portion 30 is connected to the propping portion 40. The insertion portion 30 and the propping portion 40 are preferably formed in one piece. In detail, the insertion portion 30 includes a first insertion portion 32 and a second insertion portion 34, and the second insertion portion 34 extends from the end point of the first insertion portion 32, and the first insertion portion 32 is connected to the second insertion portion 34. The propping portion 40 includes a buffer portion 42 and an expansion portion 44. The buffer portion 42 extends from the end point of the second insertion portion 34, and the expansion portion 44 extends from the end point of the buffer portion 42. The buffer portion 42 is connected to the second insertion portion 34 and the expansion portion 44.
需要特別說明的是,在加工時,針體12係將一預先裁切的薄板材再經過以對稱軸(即y方向)向內彎折而成類似U字形或是V字形的立體造型,因此針體12內部殼體的底部(或底部中點)之連線L係平行於彎折之對稱軸(即y方向)。為了容易說明起見,圖5之x-y平面剖面圖係顯示針體12在彎折前仍為平坦薄板材的情況,而由於針體12係相對於彎折之對稱軸(即y方向)為對稱,故圖5僅顯示半側的情況。It should be noted that during processing, the needle body 12 is a pre-cut thin plate that is bent inward along the symmetry axis (i.e., the y direction) to form a three-dimensional shape similar to a U-shape or a V-shape, so the line L connecting the bottom (or the midpoint of the bottom) of the inner shell of the needle body 12 is parallel to the symmetry axis of the bend (i.e., the y direction). For the sake of easy explanation, the x-y plane cross-sectional view of FIG. 5 shows the needle body 12 as a flat thin plate before bending, and because the needle body 12 is symmetrical relative to the symmetry axis of the bend (i.e., the y direction), FIG. 5 only shows the half side.
如圖5所示,以針體12之尖端為起點,從上到下依序為第一插入部32,第二插入部34、緩衝部42及擴大部44。特別地,第一插入部32、第二插入部34、緩衝部42及擴大部44每一者的邊緣皆為直線,且各自以相對於針體12向內彎折之對稱軸(即y方向)以不同的角度延伸。特別地,如圖5所示,第一插入部32邊緣的起點與終點之連線與針體12向內彎折之對稱軸(即y方向)之間具有第一夾角θ1,第二插入部34邊緣的起點與終點之連線與針體12向內彎折之對稱軸(即y方向)之間具有第二夾角θ2。緩衝部42邊緣的起點與終點之連線與針體12向內彎折之對稱軸(即y方向)之間具有第三夾角θ3,擴大部44邊緣的起點與終點之連線與針體12向內彎折之對稱軸(即y方向)之間具有第四夾角θ4。特別說明的是,在此實施例中,針體12內部殼體的底部(或底部中點)之連線L係平行於彎折之對稱軸(即y方向),因此第一夾角θ1、第二夾角θ2、第三夾角θ3、與第四夾角θ4亦可以連線L作為參照基準。As shown in FIG5 , starting from the tip of the needle body 12, from top to bottom, there are the first insertion portion 32, the second insertion portion 34, the buffer portion 42, and the expansion portion 44. In particular, the edges of each of the first insertion portion 32, the second insertion portion 34, the buffer portion 42, and the expansion portion 44 are straight lines, and each extends at a different angle relative to the symmetry axis (i.e., the y direction) of the inward bending of the needle body 12. In particular, as shown in FIG5 , a first angle θ1 is formed between a line connecting the starting point and the end point of the edge of the first insertion portion 32 and the symmetry axis (i.e., the y direction) of the inward bending of the needle body 12, and a second angle θ2 is formed between a line connecting the starting point and the end point of the edge of the second insertion portion 34 and the symmetry axis (i.e., the y direction) of the inward bending of the needle body 12. A third angle θ3 is formed between the line connecting the starting point and the end point of the edge of the buffer portion 42 and the symmetric axis (i.e., the y direction) of the inward bending of the needle body 12, and a fourth angle θ4 is formed between the line connecting the starting point and the end point of the edge of the expansion portion 44 and the symmetric axis (i.e., the y direction) of the inward bending of the needle body 12. It is particularly noted that in this embodiment, the line L connecting the bottom (or the midpoint of the bottom) of the inner shell of the needle body 12 is parallel to the symmetric axis of the bending (i.e., the y direction), so the first angle θ1, the second angle θ2, the third angle θ3, and the fourth angle θ4 can also be referenced by the line L.
較佳地,第四夾角θ4大於第三夾角θ3,第三夾角θ3大於第二夾角θ2,第二夾角θ2大於第一夾角θ1。較佳地,第一夾角θ1、第二夾角θ2、第三夾角θ3及第四夾角θ4均為銳角。較佳地,第一夾角θ1與第二夾角θ2的總和介於0°至90°之間,第二夾角θ2與第三夾角θ3的總和介於0°至90°之間,第三夾角θ3與第四夾角θ4的總和介於0°至90°之間。Preferably, the fourth angle θ4 is greater than the third angle θ3, the third angle θ3 is greater than the second angle θ2, and the second angle θ2 is greater than the first angle θ1. Preferably, the first angle θ1, the second angle θ2, the third angle θ3 and the fourth angle θ4 are all sharp angles. Preferably, the sum of the first angle θ1 and the second angle θ2 is between 0° and 90°, the sum of the second angle θ2 and the third angle θ3 is between 0° and 90°, and the sum of the third angle θ3 and the fourth angle θ4 is between 0° and 90°.
舉例而言,當圖5所示第一插入部32的第一夾角θ1為銳角時,在經過彎折後形成針體12時,其能夠減少穿刺皮膚所需要的力量,且降低針體對皮膚造成的傷口大小,進而減輕在受測過程中受測者的不適感。第二插入部34的功能是大致維持第一插入部32的銳角角度,亦即延續第一插入部32的功能,其中第一夾角θ1與第二夾角θ2的總和介於0°至90°之間,惟第二夾角θ2需大於第一夾角θ1。在一實施例中第一夾角θ1小於5°,較佳為4°,更佳為3°;第二夾角θ2小於15°,然而第一夾角θ1和第二夾角θ2並不限於上述角度,只需符合第一夾角θ1與第二夾角θ2的總和介於0°至90°之間,例如第一夾角θ1與第二夾角θ2的總和小於20°,就能達到使針體12插入皮膚時減緩受測者的不適感。For example, when the first angle θ1 of the first insertion portion 32 shown in FIG5 is sharp, when the needle body 12 is formed after bending, it can reduce the force required to puncture the skin and reduce the size of the wound caused by the needle body to the skin, thereby reducing the discomfort of the subject during the test. The function of the second insertion portion 34 is to roughly maintain the sharp angle of the first insertion portion 32, that is, to continue the function of the first insertion portion 32, wherein the sum of the first angle θ1 and the second angle θ2 is between 0° and 90°, but the second angle θ2 needs to be greater than the first angle θ1. In one embodiment, the first angle θ1 is less than 5°, preferably 4°, and more preferably 3°; the second angle θ2 is less than 15°, however, the first angle θ1 and the second angle θ2 are not limited to the above angles, as long as the sum of the first angle θ1 and the second angle θ2 is between 0° and 90°, for example, the sum of the first angle θ1 and the second angle θ2 is less than 20°, the discomfort of the subject can be reduced when the needle 12 is inserted into the skin.
如圖5所示,緩衝部42將第二插入部34的第二夾角θ2再放大。緩衝部42的第三夾角θ3,使得針體12在擴大注射開口同時,能減緩受測者的不適感。擴大部44隨後從緩衝部的終點延伸。擴大部44具有第四夾角θ4,其功能為延續緩衝部42的銳角以擴大注射開口,並藉由擴大的注射開口使針體12完全進入皮下組織,以及藉由增加針體12內部的空間將生化感測器完整包覆在內。再者,第三夾角θ3與第四夾角θ4的總和介於0°至90°之間。較佳地,第三夾角θ3與第四夾角θ4的總和小於32°。As shown in FIG5 , the buffer portion 42 further enlarges the second angle θ2 of the second insertion portion 34. The third angle θ3 of the buffer portion 42 enables the needle body 12 to reduce the discomfort of the subject while expanding the injection opening. The expansion portion 44 then extends from the end point of the buffer portion. The expansion portion 44 has a fourth angle θ4, which functions to extend the sharp angle of the buffer portion 42 to expand the injection opening, and to allow the needle body 12 to fully enter the subcutaneous tissue through the expanded injection opening, and to completely cover the biochemical sensor by increasing the space inside the needle body 12. Furthermore, the sum of the third angle θ3 and the fourth angle θ4 is between 0° and 90°. Preferably, the sum of the third angle θ3 and the fourth angle θ4 is less than 32°.
此外,第一插入部32的直線邊緣在y方向的長度L1介於0.7mm至1.7mm之間;第二插入部34的直線邊緣在y方向的長度L2介於0.3mm至0.7mm之間;緩衝部42的直線邊緣在y方向的長度L3介於0.18mm至0.42mm之間;擴大部44的直線邊緣在y方向的長度L4介於0.3mm至0.7mm之間。In addition, the length L1 of the straight edge of the first insertion portion 32 in the y direction is between 0.7 mm and 1.7 mm; the length L2 of the straight edge of the second insertion portion 34 in the y direction is between 0.3 mm and 0.7 mm; the length L3 of the straight edge of the buffer portion 42 in the y direction is between 0.18 mm and 0.42 mm; and the length L4 of the straight edge of the expansion portion 44 in the y direction is between 0.3 mm and 0.7 mm.
在一實施例中,第一插入部32的邊緣、第二插入部34的邊緣、緩衝部42的邊緣、擴大部44的邊緣至少其中之一為直線邊緣,而不需要如圖5所示,全部都是直線邊緣。In one embodiment, at least one of the edge of the first inserting portion 32, the edge of the second inserting portion 34, the edge of the buffer portion 42, and the edge of the expansion portion 44 is a straight edge, and it is not necessary that all of them are straight edges as shown in FIG. 5 .
根據圖6之x-y平面剖面圖係顯示針體12在彎折前仍為平坦的薄板材的另一實施例。相較於圖5中第一插入部32、第二插入部34、緩衝部42及擴大部44的直線邊緣,為了讓針體12在插入皮膚的過程中能減少銳利感及提升針體12的機械強度,圖6中第一插入部32、第二插入部34、緩衝部42及擴大部44在不改變各自起點與終點之間的連線(其為直線)與針體12向內彎折之對稱軸(即y方向)之間的夾角的前提下,第一插入部32、第二插入部34、緩衝部42及擴大部44的邊緣可以從直線改為圓弧線,且可以具有不同圓弧半徑。例如,第一插入部32的邊緣的圓弧半徑R1介於5.5mm至6mm;第二插入部34的邊緣的圓弧半徑R2介於10mm至10.8mm;緩衝部42的邊緣的圓弧半徑R3介於19.35mm至20mm;擴大部44的邊緣的圓弧半徑R4介於0.2mm至2.4mm。當針體12由相同材料所組成時,圓弧狀邊緣的應力會大於直線邊緣的應力,故本創作之具有圓弧邊緣的針體12結構可以增加結構應力,同時可以提升插入使用者皮膚的機械強度,進而達到保護內部生化感測器的效果。The x-y plane cross-sectional view of FIG6 shows another embodiment in which the needle body 12 is still a flat thin plate before being bent. Compared with the straight edges of the first insertion portion 32, the second insertion portion 34, the buffer portion 42 and the expansion portion 44 in FIG. 5, in order to reduce the sharpness of the needle body 12 during the insertion of the skin and to enhance the mechanical strength of the needle body 12, the edges of the first insertion portion 32, the second insertion portion 34, the buffer portion 42 and the expansion portion 44 in FIG. 6 can be changed from straight lines to arc lines, and can have different arc radii, without changing the angle between the line connecting the starting point and the end point (which is a straight line) and the symmetry axis (i.e., the y direction) of the inward bending of the needle body 12. For example, the arc radius R1 of the edge of the first insertion portion 32 is between 5.5 mm and 6 mm; the arc radius R2 of the edge of the second insertion portion 34 is between 10 mm and 10.8 mm; the arc radius R3 of the edge of the buffer portion 42 is between 19.35 mm and 20 mm; the arc radius R4 of the edge of the expansion portion 44 is between 0.2 mm and 2.4 mm. When the needle body 12 is composed of the same material, the stress of the arc edge will be greater than the stress of the straight edge. Therefore, the needle body 12 structure with an arc edge of the present invention can increase the structural stress and at the same time improve the mechanical strength of the inserted user's skin, thereby achieving the effect of protecting the internal biochemical sensor.
特別地,如圖6所示,在第一插入部32、第二插入部34、緩衝部42及擴大部44的邊緣上相鄰的圓弧邊緣可以為反向,以增強針體12的機械強度,例如第二插入部34的圓弧邊緣與擴大部44的圓弧邊緣為向外突出,而緩衝部42的圓弧邊緣則為向內凹,而不同於第二插入部34和擴大部44的圓弧方向。較佳地,第一插入部32的圓弧邊緣係向內凹。In particular, as shown in FIG6 , the arc edges adjacent to each other on the edges of the first insertion portion 32, the second insertion portion 34, the buffer portion 42 and the expansion portion 44 may be in opposite directions to enhance the mechanical strength of the needle body 12, for example, the arc edges of the second insertion portion 34 and the expansion portion 44 may protrude outward, while the arc edges of the buffer portion 42 may be concave inward, which is different from the arc directions of the second insertion portion 34 and the expansion portion 44. Preferably, the arc edge of the first insertion portion 32 is concave inward.
在另一實施例中,第一插入部32的邊緣、第二插入部34的邊緣、緩衝部42的邊緣、擴大部44的邊緣中的至少之一為圓弧邊緣。In another embodiment, at least one of the edge of the first inserting portion 32, the edge of the second inserting portion 34, the edge of the buffer portion 42, and the edge of the expansion portion 44 is an arc edge.
圖7係為針體12一側的示意圖,其中針體12對稱於L軸,且所示之y-z視角圖係顯示針體12經彎折後的成品。在此實施例中,針體12一側外部殼體的夾角係設計為逐漸變大。如圖7所示,生理感測裝置10的針體12具有外部殼體14及內部殼體16。在靠近針體12尖端的位置,其一側外部殼體的夾角可先具有第五夾角θ5,隨後再變化增加為第六夾角θ6。而第六夾角θ6開始的位置係較佳對應於針體12可以完全容納生化感測器的位置(也就是生化感測器設置於該內部殼體的起點位置),而第五夾角θ5開始的位置係較佳對應於針體12尖端處還沒有放置生化感測器的位置。FIG7 is a schematic diagram of one side of the needle body 12, wherein the needle body 12 is symmetrical to the L axis, and the y-z perspective diagram shown is a finished product after the needle body 12 is bent. In this embodiment, the angle of the outer shell on one side of the needle body 12 is designed to gradually increase. As shown in FIG7, the needle body 12 of the physiological sensing device 10 has an outer shell 14 and an inner shell 16. At a position close to the tip of the needle body 12, the angle of the outer shell on one side may first have a fifth angle θ5, and then change to increase to a sixth angle θ6. The starting position of the sixth angle θ6 preferably corresponds to the position where the needle body 12 can completely accommodate the biochemical sensor (that is, the starting position where the biochemical sensor is set in the inner shell), and the starting position of the fifth angle θ5 preferably corresponds to the position at the tip of the needle body 12 where the biochemical sensor is not yet placed.
較佳地,第五夾角θ5與第六夾角θ6係為銳角,其中第五夾角θ5的定義為以Y軸方向上的L線為中心線,分別沿著L線的兩側形成的夾角總和。另外,第六夾角θ6的定義與第五夾角θ5相同。較佳地,第五夾角θ5介於10°至12°之間;第六夾角θ6大於第五夾角θ5;以及第五夾角θ5與第六夾角θ6的總和介於0°至90°之間。Preferably, the fifth angle θ5 and the sixth angle θ6 are sharp angles, wherein the fifth angle θ5 is defined as the sum of angles formed along both sides of the L line with the L line in the Y-axis direction as the center line. In addition, the definition of the sixth angle θ6 is the same as the fifth angle θ5. Preferably, the fifth angle θ5 is between 10° and 12°; the sixth angle θ6 is greater than the fifth angle θ5; and the sum of the fifth angle θ5 and the sixth angle θ6 is between 0° and 90°.
由於本創作的生理感測裝置的針體可使得生化感測器在注射過程中能夠位於針體的保護範圍內,且因為針體的內部殼體的形狀與生化感測器的形狀不同,即使生化感測器和針體的內部殼體在操作過程中產生接觸,也可以減少生化感測器與針體的接觸面積,進而降低生化感測器的電極面與針體接觸的可能性。再者,藉由針體的插入部、擴大部及漸進式的角度的外形構造,可以降低受測者在受測過程中的不適感。Because the needle of the physiological sensing device of the invention can make the biochemical sensor be located within the protection range of the needle during the injection process, and because the shape of the inner shell of the needle is different from the shape of the biochemical sensor, even if the biochemical sensor and the inner shell of the needle come into contact during the operation, the contact area between the biochemical sensor and the needle can be reduced, thereby reducing the possibility of the electrode surface of the biochemical sensor and the needle coming into contact. Furthermore, the discomfort of the subject during the test can be reduced by the outer shape structure of the insertion part, the expansion part and the gradual angle of the needle.
本創作在上文中已以較佳實施例揭露,然熟習本項技術者應理解的是,實施例僅用於描繪本創作,而不應解讀為限制本創作的範圍。另應注意的是,舉凡與實施例等效的修飾與置換,均應涵蓋於本創作的範圍內。因此,本創作的保護範圍當以申請專利範圍所界定者為準。The present invention has been disclosed in the above with preferred embodiments, but those skilled in the art should understand that the embodiments are only used to describe the present invention and should not be interpreted as limiting the scope of the present invention. It should also be noted that all modifications and replacements equivalent to the embodiments should be included in the scope of the present invention. Therefore, the scope of protection of the present invention shall be subject to the scope defined by the patent application.
10:生理感測裝置 12:針體 14:外部殼體 16:內部殼體 18:生化感測器 20:電極面 22:第一邊 24:第二邊 26:第一面 28:第二面 30:插入部 32:第一插入部 34:第二插入部 40:撐開部 42:緩衝部 44:擴大部 H1:第一長度 H2:第二長度 Hc:縱向長度 W:生化感測器的高度 θ1:第一夾角 θ2:第二夾角 θ3:第三夾角 θ4:第四夾角 θ5:第五夾角 θ6:第六夾角 A:接觸點 B:接觸點 L:底部(或底部中點)之連線 10: Physiological sensing device 12: Needle body 14: External housing 16: Internal housing 18: Biochemical sensor 20: Electrode surface 22: First side 24: Second side 26: First side 28: Second side 30: Insertion part 32: First insertion part 34: Second insertion part 40: Spreading part 42: Buffer part 44: Expansion part H1: First length H2: Second length Hc: Longitudinal length W: Height of biochemical sensor θ1: First angle θ2: Second angle θ3: Third angle θ4: Fourth angle θ5: Fifth angle θ6: Sixth angle A: Contact point B: contact point L: bottom (or bottom midpoint) connection line
為能充分理解本創作所揭露的內容,應結合附圖並參考以下描述。In order to fully understand the content revealed by this work, the following description should be read in conjunction with the attached pictures.
圖1為本創作之生理感測裝置的立體截面圖。FIG1 is a three-dimensional cross-sectional view of the physiological sensing device of the present invention.
圖2為本創作之不同實施例的生理感測裝置的仰視圖。FIG. 2 is a bottom view of a physiological sensing device according to different embodiments of the present invention.
圖3為本創作之生理感測裝置內的生化感測器與針體的內部殼體接觸的仰視圖。FIG. 3 is a bottom view showing the biochemical sensor in the physiological sensing device of the present invention in contact with the inner shell of the needle body.
圖4為本創作之針體結構的部分示意圖。FIG. 4 is a partial schematic diagram of the needle structure of this invention.
圖5為本創作之一實施例的針體結構的部分示意圖。FIG5 is a partial schematic diagram of the needle structure of one embodiment of the present invention.
圖6為本創作之另一實施例的針體結構的部分示意圖。FIG6 is a partial schematic diagram of a needle structure of another embodiment of the present invention.
圖7為本創作生理感測裝置的針體一側的示意圖。FIG. 7 is a schematic diagram of one side of the needle body of the physiological sensing device of the present invention.
10:生理感測裝置 10: Physiological sensing device
12:針體 12: Needle body
14:外部殼體 14: External shell
16:內部殼體 16: Inner shell
18:生化感測器 18: Biochemical sensor
22:第一邊 22: First side
24:第二邊 24: Second side
26:第一面 26: First page
28:第二面 28: Second side
H1:第一長度 H1: First length
H2:第二長度 H2: Second length
Hc:縱向長度 Hc: longitudinal length
Claims (13)
Publications (1)
Publication Number | Publication Date |
---|---|
TWM659071U true TWM659071U (en) | 2024-08-11 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1490142B1 (en) | Atraumatic insertion of a subcutaneous device | |
US7824382B2 (en) | Needle tip | |
US20170086686A1 (en) | Pressure Measurement Designs | |
JP3483566B2 (en) | Electrode connector | |
JP3834724B2 (en) | Catheter fixation device | |
US20170325725A1 (en) | Vivo sensing and infusion devices | |
KR20070044456A (en) | Multiple tip lancet | |
WO2011122350A1 (en) | Puncture needle and puncture tool | |
JP7143305B2 (en) | lancing device | |
CA3107791C (en) | Needle assemblies containing oriented acupuncture needles and methods for production thereof | |
MX2008010539A (en) | Lancet. | |
CN114504700B (en) | Puncture needle and catheter assembly | |
JP2022188216A (en) | Manufacturing method of needle member | |
US11602309B2 (en) | Needle member, sensor, and method for manufacturing needle member | |
TWM659071U (en) | Physiological sensing device | |
JP4980243B2 (en) | Puncture needle and lancet provided with the same | |
US20190216371A1 (en) | In vivo sensing and infusion devices | |
TWI793800B (en) | Insertion needle structure and inserter | |
JP7148522B2 (en) | Needle member, sensor, needle member manufacturing method, and sensor manufacturing method | |
US10357618B2 (en) | Injection-needle cover | |
US20220248987A1 (en) | In vivo sensing and infusion devices | |
CN221308195U (en) | Continuous blood sugar monitoring device |